Corcept Therapeutics CORT Return on invested capital

Return on invested capital at other companies

XER

Xeris Biopharma Holdings, Inc.XERS

21.7%+17.8pp

Crinetics PharmaceuticalsCRNX

-45.1%+1.9pp

Cullinan Therapeutics, Inc.CGEM

-58%+22.6pp

ImmunomeIMNM

-746.6%+212pp

Arcus BiosciencesRCUS

-116%+139pp

Nektar TherapeuticsNKTR

-35.4%-12.2pp

FAQ

What is Corcept Therapeutics's return on invested capital?

Corcept Therapeutics (CORT) reported return on invested capital of 1.1% in Q2 2026.

How has Corcept Therapeutics's return on invested capital changed year-over-year?

Corcept Therapeutics's return on invested capital decreased by 94.4% year-over-year, from 20.1% to 1.1%.

What is the long-term trend for Corcept Therapeutics's return on invested capital?

Over 5 years (2020 to 2025), Corcept Therapeutics's return on invested capital has grown at a -20.6% compound annual growth rate (CAGR), from 26% to 8.2%.

What does return on invested capital mean?

Net operating profit after tax (operating income taxed at the effective rate) divided by average invested capital (debt plus equity minus cash). Measures the after-tax return on all capital put to work in the business, independent of capital structure.